Clinical Trial Supplies Research Report 2026: $4.33 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, And Forecasts, 2020-2025, 2025-2030F, 2035F

(MENAFN- GlobeNewsWire - Nasdaq) Expanding clinical trials, decentralization, and digital trial tools offer key market opportunities. Increased demand for biologics, CRO outsourcing, temperature-controlled logistics, and regulatory focus are growth drivers. North America leads, while Asia-Pacific shows rapid growth.

Dublin, April 24, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Supplies Market Report 2026" has been added to ResearchAndMarkets's offering.

The global clinical trial supplies market is on a robust growth trajectory, expanding from $2.86 billion in 2025 to an estimated $3.1 billion in 2026, reflecting a CAGR of 8.3%. This growth has been fueled by increased clinical trial activity worldwide, the expansion of multicenter trial designs, the rise of biologics and specialty drugs, and the outsourcing trend to Contract Research Organizations (CROs). The development of cold-chain logistics has further bolstered this upward trend.

Looking ahead, the market is projected to reach $4.33 billion by 2030, with a CAGR of 8.7%. The forecasted growth is driven by the increasing complexity of clinical trial protocols and the expansion of decentralized and virtual trials. The industry is also focusing on patient-centric trial models and investing significantly in digital trial management tools amidst growing regulatory scrutiny across regions. Notable trends include the adoption of integrated supply chain platforms, use of temperature-controlled logistics, and adaptive packaging and labeling services.

The clinical trial supplies market's growth is significantly influenced by the rising number of registered clinical trials, reflecting a surge in global medical research activities. As of May 2023, reported 437,533 registered trials, up from 399,499 in 2022. This increase underscores the essential role of clinical trial supplies in ensuring successful trials, accurate data collection, and patient safety.

Innovative technologies are being embraced by leading players in the market to transform healthcare decision-making. A prime example is Komodo Health, which launched the MapEnhance platform in April 2023. This real-world evidence technology offers deep insights into clinical events and patient data through a network of specialty data partners.

In a notable development, Myonex, a U.S.-based pharmaceutical company, acquired Creapharm's pharmaceutical services in May 2024. This acquisition enhances service offerings in clinical and commercial stages for pharmaceutical and biotech firms, including those involved with Advanced Therapies. Creapharm, based in France, is renowned for its clinical packaging and distribution capabilities.

Prominent companies in the clinical trial supplies market include Thermo Fisher Scientific Inc., IQVIA, Eurofins Scientific SE, Catalent Inc., Parexel International Corporation, ICON PLC, and several others. These companies continue to push boundaries to meet the growing demand for trial supplies in North America, the largest regional market thus far, with Asia-Pacific expected to lead future growth.

The dynamic landscape of tariffs is also shaping the market, impacting costs related to imported packaging and logistics components. This is leading to extended trial timelines and increased operational budgets in North America and Europe, but also spurring regional supply hub development and resilient sourcing strategies.

The clinical trial supplies market report, part of a series of new insights, provides comprehensive data, statistics, and analysis of market size, regional shares, and emerging trends. It offers an in-depth perspective on the current and future scenarios of the industry, addressing key areas such as logistics, packaging, and supply chain management, essential for fortifying the growth of the global clinical trial supplies market.

Key Attributes:

Report Attribute	Details
No. of Pages	250
Forecast Period	2026 - 2030
Estimated Market Value (USD) in 2026	$3.1 Billion
Forecasted Market Value (USD) by 2030	$4.33 Billion
Compound Annual Growth Rate	8.7%
Regions Covered	Global

Key Technologies & Future Trends

• Increasing Adoption of Integrated Supply Chain Platforms
• Rising Use of Temperature-Controlled Logistics Solutions
• Growing Demand for End-to-End Trial Visibility
• Expansion of Adaptive Packaging and Labeling Services
• Enhanced Focus on Compliance and Traceability

Report Scope:

• By Services: Logistics, Storage, Supply Chain Management, Packaging, Comparator Sourcing
• Clinical Phases: I, II, III, IV
• Therapeutic Uses: Oncology, CNS, Cardiovascular, Infectious Disease, Metabolic Disorders, Others
• End Users: Pharmaceutical and Biotech Companies, CROs

Companies Featured

• Thermo Fisher Scientific Inc.
• IQVIA
• Eurofins Scientific SE
• Parexel International Corporation
• ICON PLC
• Catalent Inc.
• Intertek Group PLC
• Recipharm AB
• World Courier
• Almac Group Ltd.
• Piramal Pharma Solutions
• Clinigen Group PLC
• Movianto GmbH
• Marken Limited
• PCI Pharma Services
• Rubicon Research Private Limited
• Bionical Ltd.
• Durbin PLC
• SIRO Clinpharm Pvt. Ltd.
• Biocair International Ltd.
• Ancillare LP.
• Myonex
• Klifo A/S
• Alium Medical Limited
• ADAllen Pharma
• Sharp Services LLC

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Clinical Trial Supplies Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN24042026004107003653ID1111026839